Arteris Inc. (AIP)
NASDAQ (NMS) NASDAQ (NMS) Primary 
Arteris: Unlocking Long-Term Value In The AI Semiconductor Ecosystem
Arteris is a critical, undervalued enabler of AI and advanced chips, with a high-margin, compounding royalty business model overlooked due to current GAAP losses. The company boasts a strong balance sheet, minimal debt, and is investing heavily in R&D to secure long-term royalty streams, recently validated by a major AMD partnership. My valuation, using conservative peer multiples and projected revenue growth, supports a $23 price target—over 50% upside from current levels, justifying a strong buy rating.
Arteris, Inc. (AIP) Q2 2025 Earnings Call Transcript
Arteris, Inc. (NASDAQ:AIP ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Karel Charles Janac - Chairman, CEO & President Nicholas Bryan Hawkins - VP & CFO Conference Call Participants Auguste Philip Richard - Northland Capital Markets, Research Division Joshua Louis Buchalter - TD Cowen, Research Division Kevin Garrigan - Rosenblatt Securities Inc., Research Division Erica L. Mannion - Sapphire Investor Relations, LLC Operator Good afternoon, everyone, and welcome to the Arteris Second Quarter 2025 Earnings Call.
Arteris, Inc. (AIP) Reports Q2 Loss, Tops Revenue Estimates
Arteris, Inc. (AIP) came out with a quarterly loss of $0.11 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.11 per share a year ago.
Arteris (AIP) Moves 12.2% Higher: Will This Strength Last?
Arteris (AIP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Arteris, Inc. (AIP) Q1 2025 Earnings Call Transcript
Arteris, Inc. (NASDAQ:AIP ) Q1 2025 Earnings Conference Call May 13, 2025 4:30 PM ET Company Participants Erica Mannion - Sapphire IR Charlie Janac - CEO Nick Hawkins - CFO Conference Call Participants Josh Buchalter - TD Cowen Kevin Garrigan - Rosenblatt Securities Gus Richard - Northland Blayne Curtis - Jefferies Operator Good afternoon everyone and welcome to the Arteris' First Quarter 2025 Earnings Call. Please note, this call is being recorded and simultaneously webcast.
Arteris, Inc. (AIP) Reports Q1 Loss, Tops Revenue Estimates
Arteris, Inc. (AIP) came out with a quarterly loss of $0.09 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to loss of $0.15 per share a year ago.
Arteris (AIP) Surges 8.6%: Is This an Indication of Further Gains?
Arteris (AIP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Arteris Q4: Long Growth Runway Ahead Overshadowed By The Lack Of Profitability
Arteris Q4: Long Growth Runway Ahead Overshadowed By The Lack Of Profitability
Arteris, Inc. (AIP) Q4 2024 Earnings Call Transcript
Arteris, Inc. (NASDAQ:AIP ) Q4 2024 Earnings Conference Call February 18, 2025 4:30 PM ET Company Participants Erica Mannion – Sapphire Investor Relations Charlie Janac – Chief Executive Officer Nick Hawkins – Chief Financial Officer Conference Call Participants Gus Richard – Northland Kevin Garrigan – Rosenblatt Securities Ethan Potasnick – TD Cowen Operator Good afternoon, everyone, and welcome to the Arteris Fourth Quarter and Full Year 2024 Earnings Call. Please note, this call is being recorded and simultaneously webcast.
Arteris, Inc. (AIP) Reports Q4 Loss, Tops Revenue Estimates
Arteris, Inc. (AIP) came out with a quarterly loss of $0.10 per share in line with the Zacks Consensus Estimate. This compares to loss of $0.18 per share a year ago.
Arteris (AIP) Upgraded to Buy: Here's What You Should Know
Arteris (AIP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Arteris (AIP) Moves 7.0% Higher: Will This Strength Last?
Arteris (AIP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
